Alexandre Detappe

26PUBLICATIONS
80CO-AUTHORS
GlycoconjugatesNanomaterialsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 30, 2026
From Payload-First Toward Dual-Mechanism Antibody-Drug Conjugates.

|Jul 13, 2025
Nanomaterials Trigger Functional Anti-Tumoral Responses in Primary Human Immune Cells.

Vincent Mittelheisser, Olivier Lefebvre, Mainak Banerjee

|Jun 09, 2025
Reinforced Polymer-Nanoparticle Hydrogels for Subcutaneous and Sustained Delivery of Trastuzumab.

Giovanni Bovone, Stéphane Bernhard, Guillaume Jacquot

|Feb 04, 2025
Spacer engineering in nanoparticle-peptide conjugates boosts targeting specificity for tumor-associated antigens.

María de Los Angeles Ramírez, Jolie Bou-Gharios, Barbara Freis

|Dec 16, 2024
Antibody-Vincristine Conjugates as Potent Anticancer Therapeutic Agents.

Agathe Boos, Julien Most, Héloïse Cahuzac

Pageof 5